SCHEMBL2981685

SCHEMBL2981685

Cc1ccc(CC2(N(C)C)CCC(NC(=O)C(C)(C)Oc3ccc(CCNC(=O)c4ccc(Cl)cc4)cc3)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 4/20 0.55
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
FABP2 P12104 1/20 0.55
PPARG P37231 1/20 0.55
PPARD Q03181 1/20 0.55
HSD11B1 P28845 4/20 0.45
NPC1 O15118 4/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 1/20 0.42
HSD11B2 P80365 2/20 0.41
MAPT P10636 2/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 2/20 0.40
CYP1A2 P05177 1/20 0.40
GAA P10253 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
GFER P55789 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2981302 0.97 PPARA (0.59) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL5161825 0.94 PPARA (0.49) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL2989373 0.92 PPARA (0.51) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL2978782 0.90 PPARA (0.53) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL4863362 0.89 PPARA (0.53) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL4870410 0.88 PPARA (0.53) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL2985298 0.88 PPARA (0.51) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL2985576 0.87 PPARA (0.60) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL2977575 0.87 PPARA (0.52) PPARAALDH1A1SMN1; SMN2FABP2PPARG
SCHEMBL2977590 0.83 PPARA (0.58) PPARAALDH1A1SMN1; SMN2FABP2PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786328-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2010-08-31 US claimed
US-20070281954-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-12-06 US claimed
US-7786328-B2 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2010-08-31 US disclosed
US-20070281954-A1 Cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281954-A1 Cyclohexyl-1,4-diamine compounds DPYD, PKD1, AOC1 PPARA 3707/4885ALDH1A1 207/4885SMN1; SMN2 895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.